Live Breaking News & Updates on Taiwan Based Sun Ten Pharmaceutical

2021/05/27 13:57
Herbal supplement NRICM101 
Herbal supplement NRICM101 
(CNA photo)
TAIPEI (Taiwan News) Taiwan-based Sun Ten Pharmaceutical Co. (順天堂) announced Wednesday (May 26) its donation to hospitals of the first batch of a herbal drug touted as being able to treat COVID-19.
Developed by the National Research Institute of Chinese Medicine (NRICM) in 2020, the treatment NRICM101 (清冠一號) contains 10 herbs, including mint, Chinese skullcap, houttuynia, and licorice.
The product has proven effective at inhibiting coronavirus replication and preventing the cytokine storm, in which the body attacks its own cells. It s said to be able to reduce the chance of severe illness in coronavirus patients without side effects, according to NRICM. ....

T Ai Pei , Chung Shan , Yang Ming Chiao , Hualian Xian , Shin Kong Wu , Chang Gung Medical Foundation , Kaohsiung Medical University Chung , Ministry Of Health , Taiwan News , National Yang Ming Chiao Tung University Hospital , National Research Institute Of Chinese Medicine , Taipei Medical University Hospital , Sun Ten Pharmaceutical Co , Chung Shan Medical University Hospital , China Medical University Hospital , Taiwan Based Sun Ten Pharmaceutical , National Research Institute , Chinese Medicine , Sen Ten , Tri Service General Hospital , Taoyuan General Hospital , Keelung Hospital , Show Chwan Memorial Hospital , Changhua Christian Hospital , National Yang Ming Chiao Tung University , டி ஐ பேய் ,